Cantor Fitzgerald’s Orion Biotech Opportunities Corp. Warrant ORIAW Stock Holding History

Cantor Fitzgerald’s Portfolio ORIAW Stock Details ORIAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-124,365	Closed	-$9.94K	–	750
2023 Q1	$9.94K	Hold	124,365	–	–	﹤0.01%	626
2022 Q4	$20K	Sell	124,365 -58,640	-32%	-$6.74K	﹤0.01%	645
2022 Q3	$20K	Hold	183,005	–	–	﹤0.01%	688
2022 Q2	$28K	Hold	183,005	–	–	﹤0.01%	739
2022 Q1	$68K	Buy	183,005 +20,060	+12%	+$10.3K	0.01%	314
2021 Q4	$156K	Buy	+162,945	New	+$170K	0.01%	289

Cantor Fitzgerald's ORIAW Position: Q2 2023 in Review

Cantor Fitzgerald sold out of Orion Biotech Opportunities Corp. Warrant (ORIAW) in Q2 2023, closing a stake of 124,365 shares — an estimated $9.94K sold.

Cantor Fitzgerald first reported a position in ORIAW in Q4 2021 and held it in 6 quarters. The position peaked at $156K in Q4 2021. 0 funds tracked by Wall St. Rank hold ORIAW as of Q2 2023.

Cantor Fitzgerald reported no remaining Orion Biotech Opportunities Corp. Warrant position as of Q2 2023 after selling out during the quarter.
Cantor Fitzgerald sold 124,365 Orion Biotech Opportunities Corp. Warrant shares in Q2 2023, an estimated $9.94K.
Cantor Fitzgerald first reported a position in Orion Biotech Opportunities Corp. Warrant in Q4 2021 and held it in 6 quarters.
Cantor Fitzgerald's Orion Biotech Opportunities Corp. Warrant position peaked at $156K in Q4 2021.
0 funds tracked by Wall St. Rank held Orion Biotech Opportunities Corp. Warrant as of Q2 2023.

Based on Cantor Fitzgerald's 13F filing for Q2 2023, filed 14 Aug 2023.